Enteric Empty Capsules Market Projected to Reach US$ 5.21 Billion by 2032, Growing at a CAGR of 6.8%

Market Overview:

The global enteric empty capsules market size is expected to reach USD 5.21 Billion by 2032, exhibiting a CAGR of 6.8% during forecast period.

Enteric empty capsules are broadly utilized in the pharmaceutical industry to distribute medication in a way that safeguards it from the acidic habitat of the stomach, sanctioning that it is let out in the intestine. These capsules are necessary for drugs that are susceptible to gastric acid or need earmarked delivery in the gastrointestinal tract. The market involves several capsule kinds, such as gelatine-dependent, vegetarian, and tailor-made capsules for particular applications. The market caters to pharmaceutical firms, contact-making establishments, and research organizations.

Growth Factors and Opportunities:

The market for enteric empty capsules is expanding due to it improving drug conveyance and amplifying assimilation by safeguarding susceptible constituents until extending the intestinal tract.

As consumers become more health-aware and conscious of dietary curtailment, there is a growing demand for vegetarian and vegan options in pharmaceuticals and nutraceuticals. Plant-dependent enteric capsules, usually rendered from substances such as hydroxypropyl methylcellulose (HPMC), provide a pragmatic solution to encounter the enteric empty capsules market demand.

Progressions in enteric coating technologies are important for sanctioning that capsules liberate their capacity in the intestines instead of their stomach. Inventions in polymer science have caused the advancement of contemporary enteric coatings that provide enhanced stability, regulated discharge, and improved safeguarding of susceptible agile constituents. These progressions are crucial for medications earmarking gastrointestinal conditions or for acid susceptible drugs where accurate conveyance is important.

Download Free Sample PDF Copy of the Report:

https://www.polarismarketresearch.com/industry-analysis/enteric-empty-capsules-market/request-for-sample

Major Companies:

The firms are conceded for their considerable commodity portfolios and robust market existence. Leaders in the enteric empty capsules market are enumerated as follows:

• Capsugel (a Lonza company)
• ACG Group
• Qualicaps
• Suheung Co., Ltd.
• Sunil Healthcare Ltd.
• Roxlor, LLC
• Medi-Caps Ltd.
• Natural Capsules Ltd.
• Capscanada Corporation
• Snail Pharma Industry Co., Ltd.
• Bright Pharma Caps, Inc.
• Patheon (a Thermo Fisher Scientific brand)
• Erawat Pharma Limited
• Dah Feng Capsule Co., Ltd.
• Shaoxing Kangke Capsule Co., Ltd.

Regional Scope:

The regions covered in the report are Europe, North America, Latin America, Asia Pacific, Middle East & Africa.

Enteric Empty Capsules Market, Regional Outlook (Revenue – USD Billion, 2019-2032)

• North America
  • Product Outlook
    • Gelatin Capsules
    • Vegetable Capsules
  • Application Outlook
    • Antacid & Antiflatulent Preparations
    • Antibiotic & Antibacterial Drugs
    • Others
  • End User Outlook
    • Pharmaceutical Manufacturers
    • Nutraceutical Manufacturers
    • Others

Europe

• • Product Outlook
    • Gelatin Capsules
    • Vegetable Capsules
  • Application Outlook
    • Antacid & Antiflatulent Preparations
    • Antibiotic & Antibacterial Drugs
    • Others
  • End User Outlook
    • Pharmaceutical Manufacturers
    • Nutraceutical Manufacturers
    • Others
• Asia Pacific
  • Product Outlook
    • Gelatin Capsules
    • Vegetable Capsules
  • Application Outlook
    • Antacid & Antiflatulent Preparations
    • Antibiotic & Antibacterial Drugs
    • Others
  • End User Outlook
    • Pharmaceutical Manufacturers
    • Nutraceutical Manufacturers
    • Others

Enteric Empty Capsules Industry Developments:

• June 2024: Lonza Expands Capsule Manufacturing Capacity
  Lonza announced a significant expansion in its capsule manufacturing capacity to address the growing demand for specialty capsules. This development underscores Lonza’s commitment to meeting market needs and solidifying its position as a leader in the specialty capsule segment.
• May 2024: ACG Launches New Line of Enteric Capsules
  ACG introduced a new range of enteric capsules tailored specifically for nutraceutical applications. These capsules cater to the increasing demand for gut health supplements and other targeted applications, showcasing ACG’s innovative approach and responsiveness to emerging market trends. This initiative emphasizes ACG’s focus on advancing capsule technology to align with consumer health needs.

The enteric empty capsules market pertains to the sector of the pharmaceutical and nutraceutical industries that involves the production, distribution, and use of enteric-coated empty capsules. These capsules are designed to protect the contents from stomach acids and deliver them to the intestines, where they can be absorbed more effectively. Enteric capsules are often used to enhance the stability, bioavailability, and efficacy of drugs and dietary supplements. The enteric empty capsules market growth can be attributed to the rising demand for drug delivery systems that enhance the efficacy and targeted release of pharmaceutical formulations. Other factors such as an increasing prevalence of gastrointestinal disorders, the expansion of the pharmaceutical and nutraceutical industries, and growing consumer preference for dietary supplements drive the market growth.